Literature DB >> 8432592

Comparison of Shiga-like toxin I B-subunit expression and localization in Escherichia coli and Vibrio cholerae by using trc or iron-regulated promoter systems.

D W Acheson1, S B Calderwood, S A Boyko, L L Lincicome, A V Kane, A Donohue-Rolfe, G T Keusch.   

Abstract

Shiga-like toxin I (SLT-I) B-subunit expression was examined by using the trc promoter in two different constructs, pSBC32 and pSBC54, in which 710 bp of DNA downstream of the B subunit in pSBC32 was deleted. The trc promoter in pSBC54 was replaced also with the SLT-I iron-regulated promoter to create a third plasmid, pSBC61. SLT-I B-subunit expression was examined from all three plasmids following transfer into Escherichia coli JM105 and the cholera toxin A-subunit gene deletion mutant Vibrio cholerae 0395-N1. The SLT-I B subunit was expressed from all constructs. pSBC61 was regulated by elemental iron and produced equivalent amounts of SLT-I B subunit from both E. coli and V. cholerae. In contrast to the cholera toxin B subunit, virtually all released into the medium, the SLT-I B subunit was predominantly cell associated in the pSBC61 constructs. Both pSBC32 and pSBC54 were inducible with isopropyl-beta-D-thiogalactopyranoside (IPTG) in the E. coli background but not the V. cholerae background; however, when E. coli cultures were allowed to grow for 24 h, the yield of SLT-I B subunit was not increased by IPTG induction. Both pSBC32 and -54 expressed more SLT-I B subunit in the V. cholerae host than in the E. coli host. Scale-up to a 9.9-liter fermentor culture of V. cholerae 0395 N1 (pSBC32) resulted in the isolation of 220 mg of SLT-I B. The purified B subunit was identical, in terms of binding to Vero cells, stoichiometry after chemical cross-linking, and ability to inhibit cytotoxicity of intact Shiga toxin, to native SLT-I B subunit from E. coli O157:H7.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432592      PMCID: PMC302844          DOI: 10.1128/iai.61.3.1098-1104.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

Review 1.  Shiga and Shiga-like toxins.

Authors:  A D O'Brien; R K Holmes
Journal:  Microbiol Rev       Date:  1987-06

2.  Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli.

Authors:  S B Calderwood; F Auclair; A Donohue-Rolfe; G T Keusch; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

3.  Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.

Authors:  Y Endo; K Tsurugi; T Yutsudo; Y Takeda; T Ogasawara; K Igarashi
Journal:  Eur J Biochem       Date:  1988-01-15

4.  Shiga toxin: production and purification.

Authors:  G T Keusch; A Donohue-Rolfe; M Jacewicz; A V Kane
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

5.  Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2.

Authors:  T Waddell; S Head; M Petric; A Cohen; C Lingwood
Journal:  Biochem Biophys Res Commun       Date:  1988-04-29       Impact factor: 3.575

6.  Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus.

Authors:  S B Calderwood; J J Mekalanos
Journal:  J Bacteriol       Date:  1987-10       Impact factor: 3.490

7.  Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin.

Authors:  R K Taylor; V L Miller; D B Furlong; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

8.  Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1.

Authors:  N A Strockbine; M P Jackson; L M Sung; R K Holmes; A D O'Brien
Journal:  J Bacteriol       Date:  1988-03       Impact factor: 3.490

9.  Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.

Authors:  M Jacewicz; H Clausen; E Nudelman; A Donohue-Rolfe; G T Keusch
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

10.  Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies.

Authors:  A Donohue-Rolfe; G T Keusch; C Edson; D Thorley-Lawson; M Jacewicz
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulum.

Authors:  Maria Teresa Tarragó-Trani; Brian Storrie
Journal:  Adv Drug Deliv Rev       Date:  2007-06-28       Impact factor: 15.470

2.  Latrunculin B facilitates Shiga toxin 1 transcellular transcytosis across T84 intestinal epithelial cells.

Authors:  Irina Maluykova; Oksana Gutsal; Marina Laiko; Anne Kane; Mark Donowitz; Olga Kovbasnjuk
Journal:  Biochim Biophys Acta       Date:  2008-02-20

3.  In vivo transduction with shiga toxin 1-encoding phage.

Authors:  D W Acheson; J Reidl; X Zhang; G T Keusch; J J Mekalanos; M K Waldor
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

4.  Syntheses and immunologic properties of Escherichia coli O157 O-specific polysaccharide and Shiga toxin 1 B subunit conjugates in mice.

Authors:  E Konadu; A Donohue-Rolfe; S B Calderwood; V Pozsgay; J Shiloach; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR.

Authors:  D W Acheson; M M Levine; J B Kaper; G T Keusch
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

6.  Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains.

Authors:  J R Butterton; E T Ryan; D W Acheson; S B Calderwood
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

7.  In vitro and in vivo analyses of constitutive and in vivo-induced promoters in attenuated vaccine and vector strains of Vibrio cholerae.

Authors:  M John; T I Crean; S B Calderwood; E T Ryan
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

8.  Expression and purification of Shiga-like toxin II B subunits.

Authors:  D W Acheson; S A De Breucker; M Jacewicz; L L Lincicome; A Donohue-Rolfe; A V Kane; G T Keusch
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

9.  Shiga toxin as a bacterial defense against a eukaryotic predator, Tetrahymena thermophila.

Authors:  William Lainhart; Gino Stolfa; Gerald B Koudelka
Journal:  J Bacteriol       Date:  2009-06-05       Impact factor: 3.490

10.  Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis.

Authors:  Irina Malyukova; Karen F Murray; Chengru Zhu; Edgar Boedeker; Anne Kane; Kathleen Patterson; Jeffrey R Peterson; Mark Donowitz; Olga Kovbasnjuk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-10-30       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.